Children's Mercy Kansas City

SHARE @ Children's Mercy
Manuscripts, Articles, Book Chapters and Other Papers
2-15-2016

Molecular Evolution and Intraclade Recombination of Enterovirus
D68 during the 2014 Outbreak in the United States.
Yi Tan
Ferdaus Hassan
Children's Mercy Hospital

Jennifer E. Schuster
Children's Mercy Hospital

Ari Simenauer
Rangaraj Selvarangan
Children's Mercy Hospital

See next page for additional authors

Follow this and additional works at: https://scholarlyexchange.childrensmercy.org/papers
Part of the Genetics and Genomics Commons, Infectious Disease Commons, Medical Genetics
Commons, Pediatrics Commons, Pulmonology Commons, and the Virus Diseases Commons

Recommended Citation
Tan, Y., Hassan, F., Schuster, J. E., Simenauer, A., Selvarangan, R., Halpin, R. A., Lin, X., Fedorova, N.,
Stockwell, T. B., Lam, T., Chappell, J. D., Hartert, T. V., Holmes, E. C., Das, S. R. Molecular Evolution and
Intraclade Recombination of Enterovirus D68 during the 2014 Outbreak in the United States. Journal of
virology 90, 1997-2007 (2016).

This Article is brought to you for free and open access by SHARE @ Children's Mercy. It has been accepted for
inclusion in Manuscripts, Articles, Book Chapters and Other Papers by an authorized administrator of SHARE @
Children's Mercy. For more information, please contact library@cmh.edu.

Creator(s)
Yi Tan, Ferdaus Hassan, Jennifer E. Schuster, Ari Simenauer, Rangaraj Selvarangan, Rebecca A. Halpin,
Xudong Lin, Nadia Fedorova, Timothy B. Stockwell, Tommy Tsan-Yuk Lam, James D. Chappell, Tina V.
Hartert, Edward C. Holmes, and Suman R. Das

This article is available at SHARE @ Children's Mercy: https://scholarlyexchange.childrensmercy.org/papers/395

crossmark

Molecular Evolution and Intraclade Recombination of Enterovirus
D68 during the 2014 Outbreak in the United States
Yi Tan,a Ferdaus Hassan,b Jennifer E. Schuster,c Ari Simenauer,a Rangaraj Selvarangan,b Rebecca A. Halpin,a Xudong Lin,a
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ABSTRACT

In August 2014, an outbreak of enterovirus D68 (EV-D68) occurred in North America, causing severe respiratory disease in children. Due to a lack of complete genome sequence data, there is only a limited understanding of the molecular evolution and epidemiology of EV-D68 during this outbreak, and it is uncertain whether the differing clinical manifestations of EV-D68 infection
are associated with specific viral lineages. We developed a high-throughput complete genome sequencing pipeline for EV-D68
that produced a total of 59 complete genomes from respiratory samples with a 95% success rate, including 57 genomes from
Kansas City, MO, collected during the 2014 outbreak. With these data in hand, we performed phylogenetic analyses of complete
genome and VP1 capsid protein sequences. Notably, we observed considerable genetic diversity among EV-D68 isolates in Kansas City, manifest as phylogenetically distinct lineages, indicative of multiple introductions of this virus into the city. In addition, we identified an intersubclade recombination event within EV-D68, the first recombinant in this virus reported to date.
Finally, we found no significant association between EV-D68 genetic variation, either lineages or individual mutations, and a
variety of demographic and clinical variables, suggesting that host factors likely play a major role in determining disease severity. Overall, our study revealed the complex pattern of viral evolution within a single geographic locality during a single outbreak, which has implications for the design of effective intervention and prevention strategies.
IMPORTANCE

Until recently, EV-D68 was considered to be an uncommon human pathogen, associated with mild respiratory illness. However,
in 2014 EV-D68 was responsible for more than 1,000 disease cases in North America, including severe respiratory illness in children and acute flaccid myelitis, raising concerns about its potential impact on public health. Despite the emergence of EV-D68, a
lack of full-length genome sequences means that little is known about the molecular evolution of this virus within a single geographic locality during a single outbreak. Here, we doubled the number of publicly available complete genome sequences of EVD68 by performing high-throughput next-generation sequencing, characterized the evolutionary history of this outbreak in detail, identified a recombination event, and investigated whether there was any correlation between the demographic and clinical
characteristics of the patients and the viral variant that infected them. Overall, these results will help inform the design of intervention strategies for EV-D68.

E

nteroviruses (EVs) are members of the family Picornaviridae
(order Picornavirales) of RNA viruses, with the genus Enterovirus comprising 12 species, designated A to H and J, as well as
rhinovirus A to C (1). All EVs are characterized by a single positive-strand RNA genome of approximately 7,500 nucleotides (nt)
in length. To date, five types of Enterovirus D (EV-D) species have
been described: EV-D68, together with EV-D70 and EV-D94, is an
important human pathogen (2–5), while EV-D111 and EV-D120
were only recently assigned (4, 6, 7). EV-D68 was first isolated
from hospitalized children with pneumonia and bronchiolitis in
California in 1962 (8), and rhinovirus 87 was later reclassified as
EV-D68 based on phylogenetic analysis, cross-neutralization, and
acid sensitivity (9–11). The EV-D68 genome includes a single
open reading frame which encodes four structural proteins (VP1
to VP4) and seven nonstructural proteins (2A to 2C and 3A to
3D), a 5= untranslated region (UTR) with a hairpin-loop secondary structure, and a 3= UTR with a poly(A) tract (1).
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EV-D68 was detected sporadically from the 1970s through the
early 2000s (12–18). However, an increased number of infections
by EV-D68 has been reported worldwide during the past decade
(15, 16, 18–33). Almost all documented EV-D68 cases during this
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MATERIALS AND METHODS
Study population and patient data collection. Patients, aged 0 to 17
years, admitted to Children’s Mercy Hospital from 1 August to 15 September 2014 with a positive test result for enterovirus/rhinovirus by
FilmArray respiratory panel assay (Biofire LLC, Idaho) were retrospectively tested for the presence of EV-D68 by real-time PCR (37). EV-D68positive patients admitted to the pediatric intensive care unit (ICU) were
age matched with two patients not requiring ICU care. Data were retrospectively obtained from chart abstraction and entered into a standardized data collection instrument. This project was approved by the Children’s Mercy Hospital Institutional Review Board.
A single-term, previously healthy infant with EV-D68 was enrolled in
an infant birth cohort based at Vanderbilt University Medical Center and
was included as a preemergent isolate in a region geographically close to
Kansas City. This is a population-based birth cohort, and respiratory ill-
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ness surveillance was performed every 2 weeks during the winter season.
All information was prospectively collected, and parents gave their informed consent for study inclusion (42).
RNA extraction and reverse transcription-PCR (RT-PCR). Extraction of viral RNA was performed at the J. Craig Venter Institute (JCVI),
Rockville, MD, with 140 l of respiratory samples (nasal swab or nasal
aspirates/wash) in transport medium using a QIAamp viral RNA minikit
(Qiagen, Hilden, Germany)/ZR96 viral RNA kit (Zymo, Irvine, CA) hybrid protocol. In brief, specimen lysis was performed in Qiagen buffer
AVL in a 96-well deep-well plate. Lysate was transferred to a ZR96 spin
plate (Zymo), and samples were processed according to the manufacturer’s protocol. The cDNA was generated using SuperScript III reverse
transcriptase (Thermo Fisher Scientific, MA) from 4 l undiluted RNA
and either oligo(dT)20 or a 1:1 mix of two primers specific to the 3=terminal region (D68_7333AR and D68_7333BR) (Table 1).
Three independent approaches were taken when performing PCR amplification of the viral genome. (i) Full-length genome amplicons containing the 3= poly(A) tail (FL-A) were generated from the cDNA generated by
oligo(dT)20 using D68_1F and M13-dt18 (reverse primer). (ii) Fulllength genome amplification excluding the 3= poly(A) tail (FL) was performed using gene-specific RT mix primers and PCR primer D68_1F and
a 1:1 mix of D68_7333AR and D68_7333BR. (iii) Generation of complete
viral genomes through the amplification of two overlapping amplicons
using gene-specific RT was achieved as follows. A small (S) 904-bp amplicon encompassing the EV-D68 5= UTR was generated directly from RNA
using the Qiagen one-step RT-PCR kit (Qiagen) according to the manufacturer’s protocol using primers D68_1F and D68_904R. A large (L)
6.8-kbp amplicon encompassing the rest of the viral genome was generated from primer D68_536F and a 1:1 mix of D68_7333AR and
D68_7333BR. Amplicons were verified on 1% agarose gels or via the
QIAxcel advanced (Qiagen) capillary gel electrophoresis DNA screening
platform, and excess primers and deoxynucleoside triphosphates
(dNTPs) were removed by treatment with exonuclease I (New England
BioLabs) and shrimp alkaline phosphatase (Affymetrix, Santa Clara, CA,
USA) at 37°C for 60 min, followed by incubation at 72°C for 15 min.
Amplicons were quantified using a SYBR green double-stranded DNA
(dsDNA) detection assay (SYBR green I nucleic acid gel stain; Thermo
Fisher Scientific), and all four amplicons per genome were pooled in equal
concentrations.
EV-D68 complete genome sequencing assembly and annotation. Illumina libraries were prepared using the Nextera DNA sample preparation kit (Illumina, Inc., San Diego, CA, USA) with half-reaction-mixture
volumes as described previously (43, 44). For samples requiring extra
coverage, the Ion Torrent Personal Genome Machine (PGM) (Thermo
Fisher Scientific) was used in addition to Illumina sequencing, in which
100 ng of pooled DNA amplicons was sheared for 7 min and Ion Torrentcompatible barcoded adapters were ligated to the sheared DNA using the
Ion Xpress Plus fragment library kit (Thermo Fisher Scientific) to create
400-bp libraries. Sequencing was performed on the Ion Torrent PGM
using 316v2 or 318v2 chips (Thermo Fisher Scientific).
Sequence reads were sorted by barcode, trimmed, and de novo assembled using CLC bio’s clc_novo_assemble program (45). The resulting contigs were searched against custom, full-length EV-D68 nucleotide databases to identify the closest reference sequence. All sequence reads were
then mapped to the selected reference EV-D68 sequence using CLC bio’s
clc_ref_assemble_long program (46). At loci where both Illumina and Ion
Torrent sequence data agreed on a variation compared with the reference
sequence, it was updated to reflect the difference. A final mapping of all
next-generation sequences to the updated reference sequences was performed with CLC bio’s clc_ref_assemble_long program (46). Curated assemblies were validated and annotated with the viral annotation software
Viral Genome ORF Reader (VIGOR) 3.0 (47) before submission to GenBank. VIGOR was used to predict genes, perform alignments, ensure the
fidelity of open reading frames, associate nucleotide polymorphisms with
amino acid changes, and detect any potential sequencing errors. The an-
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time were associated with acute respiratory infections, ranging
from mild upper respiratory tract illness and asthma to severe
bronchitis and pneumonia, with the exception of four isolated
cases associated with neurological syndromes, notably, acute flaccid myelitis (AFM), in which viruses were isolated from the cerebrospinal fluid or nasopharyngeal swabs (12, 31, 34). The 2014
outbreak of EV-D68 was the largest outbreak recorded in North
America, with more than 1,153 confirmed EV-D68 cases in 49
U.S. states and the District of Columbia (35). The majority of cases
were associated with severe respiratory illness in children (36, 37)
leading to hospitalization. In addition, there was a surge in EVD68 infections associated with AFM and encephalitis (36, 38, 39).
EV-D68 infections were reported in Europe during the same time
period, with three cases associated with AFM (40, 41).
Previous studies have revealed the presence of three major
clades of EV-D68, designated A, B and C, which have circulated or
cocirculated during different time periods in different geographic
regions (18, 38). Most of the viruses sampled from the 2014 EVD68 outbreak in the United States have been assigned to a novel
B1 subclade, especially those sampled from AFM cases (38). Along
with high rates of nucleotide substitution, recombination is an
important way in which genetic diversity can be generated in enteroviruses (33). However, no recombination events have yet been
reported in EV-D68, in part reflecting a lack of full-length genome
sequences for analysis (22).
There is growing interest in understanding the epidemiology of
EV-D68 in the United States, particularly given its association
with severe disease outcomes during the 2014 outbreak. Indeed,
little is known about the molecular evolution of the virus during a
single outbreak, nor whether differences in clinical manifestation
are associated with specific genetic variants. The most important
limitation here has been the lack of complete genome sequences of
EV-D68 in the public domain, even though such information will
assist the design of effective intervention and prevention strategies
and help formulate modalities of future treatments. To help determine the evolution of EV-D68 within a single geographic region during a single outbreak, we performed full-length genome
sequencing of viruses sampled from children seen at Children’s
Mercy Hospital—the first hospital reporting the EV-D68 outbreak in 2014 —in Kansas City, MO, during August to September
2014 (36). As well as determining the extent and pattern of viral
genetic diversity, we screened these genomic data for recombination and assessed whether there was any association between genetic variation and specific demographic and clinical features of
the infected patients.

Molecular Evolution of EV-D68

PCR

Primers

Reverse transcription
PCR
Success rate,
no. positive/
total no.
(%)

RT

Phusion Hi-Fidelity DNA
polymerase (NEB,a
MA)
Phusion Hi-Fidelity DNA
polymerase (NEB,
MA)
33/62 (53.2)

Oligo(dT)20

SuperScript III first-strand
synthesis SuperMix kit
(Thermo Fisher, MA)
SuperScript III first-strand
synthesis SuperMix kit
(Thermo Fisher, MA)
36/62 (58.0)

RT for L fragment,
SuperScript III firststrand synthesis
SuperMix kit (Thermo
Fisher, MA)

Mix of D68_7333AR, 5=-GGCCCCCAAGTG
GCCAAAATTTAC-3=, and D68_7333BR,
5=-GGTCCCCAAGTAGCCAAAATTTAC
CT-3=
Mix of D68_7333AR, 5=-GGCCCCCAAGTG
GCCAAAATTTAC-3=, and D68_7333BR,
5=-GGTCCCCAAGTAGCCAAAATTTAC
CT-3=
PCR for S, one-step RT59/62 (95.1)
PCR using Qiagen onestep RT-PCR kit; PCR
for L, Phusion HiFidelity DNA
polymerase (NEB,
MA)
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D68_1F, 5=-TTAAAACAGCCTTGGGGTTGTTCC-3=;
M13-dt18, 5=-CAGGAAACAGCTATGACCGTTTT
TTTTTTTTTTTTTT-3=
D68_1F, 5=-TTAAAACAGCCTTGGGGTTGTTCC-3=;
mix of D68_7333AR, 5=-GGCCCCCAAGTGGCCAA
AATTTAC-3=, and D68_7333BR,
5=-GGTCCCCAAGTAGCCAAAATTTACCT-3=
L, D68_1F, 5=-TTAAAACAGCCTTGGGGTTGTTCC-3=,
and D68_904R, 5=-TTCAAAACTGGNGCCCCTGCT
TT-3=; S, D68_536F, 5=-GAACCGACTACTTTGGGT
GTCCGT-3=; mix of D68_7333AR, 5=-GGCCCCCAA
GTGGCCAAAATTTAC-3=, and D68_7333BR,
5=-GGTCCCCAAGTAGCCAAAATTTACCT-3=

TABLE 1 EV-D68 primers used for three strategies of PCR amplification

Strategy of PCR
amplification

Full length with poly(A)
tail (FL-A) as single
amplicon
Full length (FL) as
single amplicon

NEB, New England BioLabs.

Overlapping two
amplicons (L and S)

a
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notation was subjected to manual inspection and quality control before
submission to GenBank.
Phylogenetic analysis. We analyzed 59 newly acquired complete genome sequences of EV-D68 (57 collected in Kansas City during the 2014
outbreak; one preoutbreak sequence collected in Nashville, TN, USA
[Vanderbilt University Medical Center], in 2012; and one prototype Fermon virus strain purchased from ATCC) together with all EV-D68 sequences
available on GenBank (http://www.ncbi.nlm.nih.gov/GenBank/). In total, we
utilized two global data sets of EV-D68: a 110-complete-genome data set
(59 JCVI-sequenced sequences and 51 background sequences) and a 357complete-VP1-gene data set (59 JCVI-sequenced sequences and 298
background sequences). Sequences within these two data sets were
aligned separately using the MUSCLE program in MEGA 6.0 with manual
adjustment (48). Maximum likelihood (ML) phylogenies (49) were inferred in MEGA 6.0. A general time reversal (GTR) substitution model
with a gamma distribution of among-site rate variation and a proportion
of invariable sites (GTR⫹⌫⫹I) was selected as the best-fit model by ModelTest in MEGA 6.0 and used in all tree inference methods. In addition,
trees were inferred using the Bayesian Markov chain Monte Carlo (BMCMC) method available in MrBayes version 3.2.5 (50), run for 1 ⫻ 108
steps. Trees were sampled every 1 ⫻ 104 steps, with the first 1,000 trees
discarded as burn-in. The robustness of the ML tree was assessed by bootstrap analyses of 1,000 pseudoreplicates and by comparison with the topologies sampled in the Bayesian analysis. All phylogenies were rooted
with the oldest EV-D68 sequence in GenBank, the Fermon strain, collected in 1962 in California, USA (2).
Inferring the events of virus introduction to Kansas City. A total of
5,000 trees were evenly subsampled from the posterior distribution of
trees produced during the BMCMC analysis described above using the
LogCombiner program within the BEAST package (51). Each sequence
was assigned a discrete geographic state— either “Kansas City” or “other
place”—according to our data or its record in GenBank. A parsimony
procedure (52) was then used to infer ancestral geographic states given
these data and hence to determine the frequency of state change from the
“other place” character state to the “Kansas City” character state in each
tree. Such changes in geographic state are indicative of independent viral
introductions into Kansas City. The mean and 95% confidence intervals
of the frequency of introduction events were summarized from the counts
in the 5,000 subsampled trees.
Analysis of EV-D68 recombination. Potential recombination within
the VP1 and complete genome sequences of EV-D68 was screened using
seven methods (RDP, GENECONV, MaxChi, Bootscan, Chimaera,
SiScan, and 3Seq) implemented in the Recombination Detection Program
version 4.46 (RDP4) (53). Phylogenetic incongruence between different
regions and with P values of less than 1 ⫻ 10⫺4 in all methods was taken to
represent strong evidence for recombination. To confirm these putative
recombination events, we utilized a smaller data set including the recombinant and the parental strains determined above, employing similarity
plots and Bootscan analysis as implemented in Simplot version 3.5.1 (54),
with a window size of 300 nucleotides (nt) and a step size of 10 nt. Recombination breakpoints were inferred based on the distribution of informative sites supporting the two incongruent tree topologies that maximized
the chi-square (2) sum (55). The midpoint of the breakpoint region was
used to partition the sequence alignment for separate phylogenetic inferences.
Assessing the association between virus phylogeny and the demographic and clinical features of EV-D68 patients. Demographic and clinical information was available for 57 outbreak samples from Kansas City.
To determine whether there was phylogenetic clustering by the age and
gender of the patient, we grouped viruses into two age classes (⬍5 years
and ⱖ5 years old) and by gender separately. Similarly, each patient was
classified as either positive or negative for each clinical symptom individually. The clinical symptoms analyzed were (i) presence in pediatric ICU,
(ii) medical history of asthma or recurrent wheezing, and (iii) requirement for ventilation. The strength of association between the phenotypic
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Schematic representation of the different approaches used to sequence the
complete EV-D68 genome. FL-A, full-length genome with poly(A) tail; FL,
full-length genome without poly(A) tail; S, small overlapping amplicon; L,
large overlapping amplicon. (B) Three examples of the EV-D68 RT PCR product—2014 outbreak strain MO49/2014, preoutbreak strain Vanderbilt
N0051U5/2012, and ATCC strain VR1197—resolved by agarose gel electrophoresis and visualized by ethidium bromide staining. Sizes of molecular
markers (in base pairs) are indicated on the left side of the gel.

features described above and the EV-D68 phylogeny was determined using two phylogeny-trait association statistics, the parsimony score (PS)
and the association index (AI) tests, both of which were implemented in
the Bayesian tip association significance testing (BaTS) program (56). A
null distribution of these statistics was determined using the posterior
distribution of trees obtained from the MrBayes analysis described above.
Nucleotide sequence accession numbers. All sequences generated as
part of this study were submitted to GenBank as part of the BioProject
identifiers PRJNA266349 and PRJNA270340 and assigned accession
numbers KT347223 to KT347280 and KT725431.

RESULTS

High-throughput full-length genome sequencing of EV-D68
from the 2014 outbreak. A total of 62 EV-D68-positive samples
were chosen for complete genome sequencing, including 60 clinical samples from the 2014 outbreak collected from Children’s
Mercy Hospital, Kansas City, MO; one preoutbreak sample from
Vanderbilt University Medical Center, Nashville, TN, collected in
2012; and one sample from the American Type Culture Collection
(ATCC), VR-1197. Oligo(dT)20 and/or two primers specific to the
3=-terminal region of the virus were used for reverse transcription
(Table 1). The general pattern of primer sites and the locations of
primer targets in EV-D68 genomes are shown in Fig. 1A. To
achieve complete genome sequencing, three approaches were attempted from respiratory samples: (i) full-length genome with
poly(A) tail (FL-A), (ii) full-length genome without the poly(A)
tail (FL), and (iii) two overlapping amplicons—large (L) and
small (S) (Fig. 1A). Representative PCR products for each method
are shown in Fig. 1B. PCR products of the expected size and complete genome assemblies were obtained with variable success rates:
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FIG 1 High-throughput sequencing of the complete genome of EV-D68. (A)

53% and 58% for FL-A and FL, respectively, and 95% (59 out of
62) for the two-amplicon method, which is superior to a recently
published method based on sequence-independent amplification
(57). These PCR products were subjected to next-generation sequencing using both the Illumina Mi-Seq and Ion Torrent sequencing platforms. In total, we obtained 59 complete genome
sequences of EV-D68, including 57 outbreak samples from Kansas
City, one preoutbreak sample from Nashville, and one historical
sample from ATCC.
Our sequencing resulted in an average of 62,256 reads/sample
with an average coverage of 1,569⫻ (minimum average coverage
of 219⫻ and maximum average coverage of 3,324⫻). Deep sequence analysis revealed an average of 4.54 single nucleotide polymorphisms (SNPs) per virus that are present in more than 3% of
reads and hence above the background level of SNPs expected
from reverse transcription, PCR, and sequencing platform-specific errors (58). Together, these new complete genome sequences
doubled the number available on GenBank.
Distinct lineages and multiple introductions of the EV-D68
viruses in Kansas City during the 2014 outbreak. Phylogenetic
analyses of the EV-D68 VP1 gene and complete genome sequences
revealed that the viruses that circulated in Kansas City during the
2014 outbreak did not form a single monophyletic group, such
that EV-D68 was clearly introduced multiple times into the city
(Fig. 2). More broadly, global VP1 phylogenies revealed the presence of the three major clades of EV-D68 —A, B, and C—which
have spread worldwide (Fig. 2A), consistent with previous studies
(18, 38). Clades A and B could be further subdivided into two
subclades each: A1 and A2 and B1 and B2. All clades and subclades
were supported by bootstrap values over 80% in the ML approach
and by posterior probabilities of 1.0 in the BMCMC approach.
All 57 outbreak samples from Kansas City fell into subclade B1.
Within this subclade, it was notable that the Kansas City viruses
fell into two monophyletic groups and were interspersed among
those viruses sampled from different states in the United States
(New York, California, and Colorado) and from different countries (Canada or France), indicating frequent gene flow between
populations (Fig. 2C). However, because of low bootstrap support
values and frequent polytomies, it is difficult to define exact
monophyletic groups of viruses from Kansas City on global VP1
phylogeny. Therefore, we estimated the number of independent
viral introductions into the Kansas City population using a parsimony reconstruction of geographic transitions, utilizing 5,000
subsampled BMCMC topologies to reflect topological uncertainty. From this, we documented an average of 10 independent
introductions of EV-D68 in to Kansas City during the outbreak,
with a 95% confidence interval between 5 and 14 introductions.
The large and well-supported monophyletic group of viruses
in subclade B1 (at the top of Fig. 2C) includes 2014 U.S. outbreak
samples collected from New York, Missouri, and California; two
2014 samples from France; and one 2014 sample from Canada.
Again, this phylogenetic pattern is indicative of both the national
and international movement of viruses. Seven Kansas City sequences did not fall in this cluster; four were closely related to each
other, while another sequence grouped with a virus from Canada.
The remaining two Kansas City sequences formed separate
branches in the tree, suggesting that they also represent independent introductions into the region. The remaining subclade B1
viruses are preoutbreak samples located near the root of the B1
cluster, including four U.S. isolates collected in 2013, a lone 2012

Molecular Evolution of EV-D68

genome sequences (B). Clades and subclades are indicated by colors and described in the trees. The bootstrap support values (percent) from 1,000 ML bootstrap
replications and posterior probabilities from BMCMC analyses (10,000 tree samples) are shown for each clade/subclade with separation by a slash. Sequences
reported by this study are shown in red and described in the key. Phylogenetic trees were rooted by the oldest EV-D68 sequence in GenBank, the Fermon strain
collected in 1962 in California, USA. (C) Magnification of subclade B1 viruses from the VP1 phylogeny (A). Sequences generated in this study are marked by red
squares in the tree. Sequences from acute flaccid myelitis (AFM) patients in the United States are marked by black squares. Sequences collected from outside the
United States have taxon names in blue. The scale bars represent the numbers of nucleotide substitutions per site.

isolate from Italy, and, notably, three Chinese isolates sampled in
2011 (Fig. 2C). In addition, only five U.S. outbreak sequences
collected in 2014 fell outside subclade B1: two from New York
(NY73 and NY74), one from Kentucky (US.KY.14.18951), and
one from Illinois (US.IL.14.18952), all of which fell in subclade
B2. Sequence US.KY.14.18953 from Kentucky fell into subclade
A2, while the preoutbreak sample collected in Nashville, Tennes-
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see, in 2012 fell into subclade A1. Finally, there are two Fermon
strain sequences in our analysis, one downloaded from GenBank
and the prototype Fermon strain that we purchased from ATCC
and sequenced. These two sequences clustered near the root, reflecting its sampling date in the 1960s (Fig. 2A).
The phylogeny of complete EV-D68 genome sequences presented the same picture of three major clades circulating world-
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FIG 2 Evolutionary history of the VP1 and complete genome sequences of EV-D68. (A and B) Global ML phylogenies estimated for the VP1 gene (A) and full

Tan et al.

trees inferred for different regions of the EV-D68 genome are indicated in black. Phylogenetic trees were rooted using the oldest EV-D68 sequence (the Fermon
strain) available on GenBank, and scale bars represent the numbers of nucleotide substitutions per site.

wide and multiple viral introductions to Kansas City during the
2014 outbreak (Fig. 2B and 3). The nucleotide similarities among
the clades ranged from 90.7% to 92.7%: clade A and clade B,
90.7%; clade A and clade C, 91.6%; and clade B and clade C,
92.7%. Nonstructural genes (2A, 2B, 2C, 3A, 3B, 3C, and 3D)
exhibited levels of heterogeneity similar to those of structural
genes (VP4, VP2, VP3, and VP1), with nucleotide similarity ranging from 96.5% to 97.1%. VP1 is the most variable gene across the
genome as a whole, displaying 96.5% nucleotide similarity.
EV-D68 recombination. We found no overt evidence of homologous recombination in the VP1 data set. However, a single
recombinant virus—strain US.KY.14.18951—was identified in
the complete genome data set, supported by P values of less than
1 ⫻ 10⫺15 in all methods. To locate the recombination breakpoints, a carefully chosen subset of sequence data (n ⫽ 22), including the recombinant strain and the closest parental lineages,
was analyzed using similarity plots and Bootscan analysis in Simplot v3.5.1. This identified one significant recombination breakpoint in VP2, at nucleotide positions 1502 to 1576 (supported by
a maximum 2 sum of 34.3), that separated the genome into two
nonrecombinant regions (Fig. 4) and which was strongly supported by phylogenetic trees inferred on either side of the breakpoint (Fig. 4C). Although the Bootscan analysis provided evidence
for a second recombination event in the 3D gene region, this
lacked statistical support. Hence, these data suggest that there was
an intersubclade recombination event between B2 and B1. In con-
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trast to subclade B1, which is the main U.S. 2014 outbreak lineage,
the majority of subclade B2 sequences were collected from Asia
and Europe during 2009 to 2014, with the exception of four U.S.
2014 outbreak sequences. Among the latter, one is the confirmed recombinant, and another is the potential parental
strain, US.IL.14.18952 (Fig. 2A).
No association between viral phylogeny and demographic
and clinical metadata. We performed two phylogeny-trait association statistics (AI and PS) to identify whether EV-D68 outbreak
strains might exhibit some phylogenetic clustering by disease severity. Notably, however, we found no significant association of
age distribution, gender ratio, or clinical symptomatology with
viral genetic variation (i.e., phylogenetic position) in the Kansas
City cohort (Table 2). Hence, phylogenetic clustering by disease
phenotype was not greater than that expected by chance alone.
Similarly, although no EV-D68-associated AFM cases were reported in Kansas City, recently reported EV-D68 sequences collected from AFM patients from Colorado and California did
not form a monophyletic group (38) but were interspersed
with sequences of EV-D68 isolates from non-AFM patients
(Fig. 2C; sequences from AFM patients marked by black rectangle).
DISCUSSION

We developed a high-throughput method to sequence complete
genomes of EV-D68, from which we were able to obtain 59 from
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FIG 3 Phylogenetic trees of the complete genome and individual genes of EV-D68. Sequences in different clades are colored as described in the key. Phylogenetic

Molecular Evolution of EV-D68

neighbor-joining phylogenetic trees with 100 bootstrap replicates inferred in each case. Bootstrap values supporting the clustering of query sequence (i.e.,
US.KY.14.18951) with different groups of reference sequences (i.e., subclade B1, subclade B2, and others) were recorded. (B) Schematic diagram of the EV-D68
genome. (C) Phylogenies inferred for nonrecombinant fragments identified by Simplot and Bootscan (A). The putative recombinant strain is marked by the black
square in the trees. Clades are indicated by the colors described in the key. Phylogenetic trees were midpoint rooted for clarity only.

the major 2014 outbreak, including 57 from Kansas City. This
doubles the number of publicly available genome sequences of
EV-D68 and allowed us to identify both multiple introduction events
into a single community and multiple cocirculating lineages worldwide, although there was no association between phylogenetic history
and a range of demographic or clinical features. Notably, we also
identified the first recombination event in EV-D68.
Until now, only limited full-length genome sequences of EVD68 from the 2014 EV-D68 outbreak in the United States have
been available in the public domain, with most coming from clinical isolates. With our high-throughput sequencing method, we
were able to generate overlapping amplicons from primary specimens to obtain the complete viral genome with a 95% success
rate. The success of this method compared to the single-amplicon

February 2016 Volume 90 Number 4

TABLE 2 Results of the phylogeny-trait association tests for particular
demographic and clinical characteristics of EV-D68 patients within
Kansas City, MO, 2014
Comparison

No. of cases
(n ⫽ 57)

AIa statistic

PSb statistic

Male
Age ⬍5 yr
PICUc
Asthma/wheezing
Requiring ventilation

39
17
18
41
8

P ⫽ 0.15
P ⫽ 0.08
P ⫽ 0.85
P ⫽ 0.82
P ⫽ 0.69

P ⫽ 0.40
P ⫽ 0.12
P⫽1
P⫽1
P ⫽ 0.53

a
b
c

AI, association index.
PS, parsimony score.
PICU, pediatric intensive care unit.
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FIG 4 Recombination analyses of the full genome of EV-D68. (A) Bootscan analysis. A sliding window of 300 nt was utilized (step size of 10 nt), with
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sequence data can predict the clinical outcome is still unclear, and
our sample size was relatively small. One finding suggestive of an
association between viral sequence diversity and clinical features is
that AFM-associated strains from the United States during the
2014 outbreak were all members of the novel outbreak subclade
B1 (38), although we were unable to identify viral genetic signatures of disease severity. Indeed, there are a number of features
that argue against a strong strain basis to virulence. First, of the
four cases of neurological conditions before the 2014 outbreak,
two cases from Kenya (strain HEV126010 in 2010 and strain
HEV199011 in 2011) were associated with viruses from subclade
A1, the endemic subclade (31), while sequence information concerning the two U.S. patients is unavailable. Second, although all
U.S. 2014 AFM cases fall in subclade B1 (38), two of three European AFM cases (40, 41) are from subclade B2. Third, the subclade
B1-associated AFM sequences do not form a single cluster but
rather are interspersed with those representing non-AFM cases
(Fig. 2C). It was recently suggested that a G272 mutation in the 5=
UTR and a series of amino acid changes in the clade B1 polyprotein (T291 in VP2, A341 in VP3, N860 in VP1, N927 in 2A, K2005
in 3D, and G1108 at the 2B/2C junction) might have increased
neurovirulence in EV-D68 (38). However, G272 was present in all
the clades studied here and the polyprotein mutations were B1
specific, not AFM specific, as they were also found in non-AFM
patients. In addition, two non-B1 AFM sequences, reported before the U.S. 2014 outbreak, possess none of the polyprotein mutations. Hence, the concentration of AFM cases in subclade B1
may simply reflect the predominance of B1 infections in the
United States (i.e., a founder effect). Indeed, it is pertinent that
EV-D68 viruses could not be isolated from cerebrospinal fluid of
AFM patients from the 2014 U.S. outbreak (38).
Although we considered only a single city in the United States
during the outbreak, these results are likely to be applicable to the
spread of EV-D68 in other modern and highly mobile populations. For an improved understanding of the factors determining
possible spatiotemporal differences in EV-D68 infection and
transmission, continuous global monitoring of the clinical and
molecular epidemiology of EV-D68 by representative surveillance
systems should clearly be a public health priority.
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approach is most likely due to RNA secondary structure in the 5=
region of the virus untranslated region that could impact the efficiency of RT-PCR.
Our phylogenetic analyses are notable in that they suggest a
relatively complex molecular evolution of EV-D68 during the
2014 outbreak. Before this outbreak, EV-D68 was rarely reported
and was associated with mild respiratory illness, although small
outbreaks had been documented since 2005 (15, 16, 18–33). Previous studies showed that the A, B, and C clades circulated or
cocirculated during different time periods in different geographic
regions (15, 16, 18, 19, 21–32, 59). We further defined subclades
A1, A2, B1, and B2. In line with our subclade definition, subclades
A1 and B2 were endemic and found in many countries before the
2014 outbreak, including Thailand during 2005 to 2010 (26), the
United Kingdom during 2009 to 2010 (27), China during 2009 to
2012 (24), Philippines from 2008 to 2014 (21–23), and the Netherlands from 1994 to 2013 (15, 29). Clade C was relatively geographically restricted, being reported in Japan during 2005 to 2010
and in Italy during 2010 to 2012 (16, 19, 30). During the 2014
outbreak, a novel subclade, B1, seems to have rapidly emerged and
was dominant during the U.S. outbreak (38, 60, 61). During the
same period, subclades A1 and B2 continued to be isolated in
European countries (40, 41, 62–65). In addition, we found multiple viral introductions from other localities into the single locality
of Kansas City during the 2014 U.S. outbreak despite the relatively
small number of sequences collected (60), indicating that EV-D68
exhibits relatively fluid spatial dynamics within the United States.
Our study is noteworthy for the observation of recombination
in EV-D68. Although recombination occurs frequently among
members of the Enterovirus genus, with interspecies recombination documented between rhinovirus A and rhinovirus B and between EV-A and EV-B (33), and intraspecies recombination
within both EV-A71 and EV-B81 (44, 66), it had not been previously definitely demonstrated to occur in EV-D68. Indeed, a previous report of phylogenetic incongruence between the 5= UTR
and VP1 could not be confirmed since only partial 5= UTR and
VP1 sequences were amplified (22). In contrast, our analysis
of ⬎100 complete EV-D68 genomes provided compelling evidence for recombination between outbreak subclade B1 and endemic subclade B2 strains, with a breakpoint in VP2. In recombination events in other enteroviruses, most breakpoints have been
documented between the structural and nonstructural regions, or
within the nonstructural region (44, 67). Interestingly, the previous report of phylogenetic incongruence between the 5= UTR
and VP1 in EV-D68 suggests the possibility of a recombination
event within the structural region (22), although this clearly
needs to be confirmed. The recombinant strain identified here,
US.KY.14.18951 from Kentucky, and the potential parental
strain in subclade B2, US.IL.14.18952 from Illinois, were both
isolated in August 2014, at the start of the 2014 outbreak (68). In
turn, the occurrence of recombination indicates that multiple distinct strains cocirculated at the beginning of the outbreak, as is
also suggested by our phylogenetic analysis. The impact of VP2centered recombination in EV-D68 evolution remains to be defined.
One of the most striking features of the 2014 outbreak was that
most EV-D68 infections were associated with severe respiratory
diseases in children (36, 40, 41, 60–65, 69). However, we found no
association between age, gender, or clinical symptoms and different viral subclades in our Kansas City population. Hence, whether
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